MedTrace Logo

Efficacy and Safety of an Infant Formula With Milkfat and Prebiotics

NCT01603719 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2020-06-09

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the effect of a new infant starter formula with added prebiotics (GOS) and with a fat blend rich in beta-palmitate.

Conditions

Interventions

DIETARY_SUPPLEMENT

new infant formula with prebiotics and beta-palmitate

experimental infant formula as sole source of nutrition over first 12 weeks of life

Sponsors & Collaborators

  • Waldkrankenhaus Protestant Hospital, Spandau

    lead OTHER

Principal Investigators

  • Frank Jochum, MD · Waldkrankenhaus Protestant Hospital, Spandau

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
10 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-10-31
Completion
2020-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01603719 on ClinicalTrials.gov